MMWR Morb Mortal Wkly Rep. 2007 Aug 31;56(34):880-5.
The National Immunization Survey (NIS) provides vaccination coverage estimates among children aged 19-35 months for each of the 50 states and selected urban and county areas. This report describes the findings of the 2006 NIS, which indicated increases in national coverage with pneumococcal conjugate vaccine (PCV) and varicella vaccine (VAR) and a stable coverage level for the 4:3:1:3:3:1 vaccine series (i.e., > or =4 doses of diphtheria, tetanus toxoid, and any acellular pertussis vaccine [DTaP]; > or =3 doses of poliovirus vaccine; > or =1 dose of measles, mumps, and rubella vaccine [MMR]; > or =3 doses of Haemophilus influenzae type b [Hib] vaccine; > or =3 doses of hepatitis B vaccine [HepB]; and > or =1 dose of VAR). However, national coverage estimates remained below the Healthy People 2010 target of 90% coverage for PCV, DTaP, and VAR and below the 80% target for the 4:3:1:3:3:1 vaccine series. No significant racial/ethnic disparities in 4:3:1:3:3:1 series coverage were observed after controlling for family income. State and local immunization programs should continue to identify and target children who are not fully vaccinated, especially because of low socioeconomic status and other barriers.
国家免疫调查（NIS）提供了美国50个州以及部分城市和县域地区19至35个月龄儿童的疫苗接种覆盖率估计数据。本报告描述了2006年NIS的调查结果，该结果显示全国肺炎球菌结合疫苗（PCV）和水痘疫苗（VAR）的接种覆盖率有所上升，4:3:1:3:3:1疫苗系列（即≥4剂白喉、破伤风类毒素和任何无细胞百日咳疫苗[DTaP]；≥3剂脊髓灰质炎疫苗；≥1剂麻疹、腮腺炎和风疹疫苗[MMR]；≥3剂b型流感嗜血杆菌[Hib]疫苗；≥3剂乙型肝炎疫苗[HepB]；以及≥1剂VAR）的接种覆盖率保持稳定。然而，全国PCV、DTaP和VAR的接种覆盖率估计仍低于《健康人民2010》设定的90%的目标，4:3:1:3:3:1疫苗系列的接种覆盖率低于80%的目标。在控制家庭收入后，未观察到4:3:1:3:3:1系列接种覆盖率存在显著的种族/民族差异。州和地方免疫计划应继续识别并针对未完全接种疫苗的儿童，特别是由于社会经济地位低和其他障碍而未接种的儿童。
